{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:18:58Z","timestamp":1792811938789,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["90056634"],"award-info":[{"award-number":["90056634"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12954-019-0312-8","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T12:02:53Z","timestamp":1560772973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-4132","authenticated-orcid":false,"given":"Salequl","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damani A.","family":"Piggott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Moriggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquie","family":"Astemborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"49","key":"312_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005617","volume":"95","author":"H Asgeirsson","year":"2016","unstructured":"Asgeirsson H, Thalme A, Weiland O. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: experience from a Swedish referral hospital. Medicine. 2016;95(49):e5617 Epub 2016\/12\/09.","journal-title":"Medicine"},{"issue":"1","key":"312_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","volume":"38","author":"D Dahlman","year":"2017","unstructured":"Dahlman D, Hakansson A, Kral AH, Wenger L, Ball EL, Novak SP. Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study. Subst Abus. 2017;38(1):105\u201312. Epub 2016\/11\/30.","journal-title":"Subst Abus"},{"issue":"3","key":"312_CR3","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","volume":"3","author":"AG Wurcel","year":"2016","unstructured":"Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, et al. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3):ofw157. Epub 2016\/11\/02.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"312_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/ADM.0000000000000346","volume":"11","author":"KT Phillips","year":"2017","unstructured":"Phillips KT, Anderson BJ, Herman DS, Liebschutz JM, Stein MD. Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs. J Addict Med. 2017;11(6):461\u20137 Epub 2017\/08\/03.","journal-title":"J Addict Med"},{"key":"312_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.04.009","volume":"163","author":"D Ciccarone","year":"2016","unstructured":"Ciccarone D, Unick GJ, Cohen JK, Mars SG, Rosenblum D. Nationwide increase in hospitalizations for heroin-related soft tissue infections: associations with structural market conditions. Drug Alcohol Depend. 2016;163:126\u201333. Epub 2016\/05\/09.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"312_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jinf.2012.10.004","volume":"66","author":"Michael Marks","year":"2013","unstructured":"Marks M, Pollock E, Armstrong M, Morris-Jones S, Kidd M, Gothard P, et al. Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. J Infect 2013;66(1):95-102. Epub 2012\/10\/17.","journal-title":"Journal of Infection"},{"issue":"1","key":"312_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/320879","volume":"33","author":"EL Murphy","year":"2001","unstructured":"Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33(1):35\u201340 Epub 2001\/06\/05.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"312_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/ADM.0000000000000093","volume":"9","author":"ME Smith","year":"2015","unstructured":"Smith ME, Robinowitz N, Chaulk P, Johnson KE. High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors. J Addict Med. 2015;9(2):87\u201393 Epub 2014\/12\/04.","journal-title":"J Addict Med"},{"key":"312_CR9","unstructured":"Alagna L, Park LP, Nicholson BP, Keiger AJ, Strahilevitz J, Morris A, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study. Clin Microbiol Infect. 2013; Epub 2013\/10\/10."},{"issue":"8","key":"312_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ejim.2007.03.012","volume":"18","author":"MB Beadsworth","year":"2007","unstructured":"Beadsworth MB, Wooton D, Chenzbraun A, Beeching NJ. Austrian\u2019s syndrome: the first described case of pneumococcal meningitis pneumonia and endocarditis in an injecting drug user. Eur J Int Med. 2007;18(8):605\u20136. Epub 2007\/12\/07.","journal-title":"Eur J Int Med"},{"issue":"18","key":"312_CR11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMra042823","volume":"353","author":"RJ Gordon","year":"2005","unstructured":"Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(18):1945\u201354 Epub 2005\/11\/04.","journal-title":"N Engl J Med"},{"key":"312_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2334-8-120","volume":"8","author":"V Hope","year":"2008","unstructured":"Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8:120. Epub 2008\/09\/20.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"312_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","volume":"83","author":"NG Shah","year":"2006","unstructured":"Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend. 2006;83(2):147\u201356 Epub 2005\/12\/21.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"312_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1360-0443.2011.03602.x","volume":"107","author":"SH Mehta","year":"2012","unstructured":"Mehta SH, Sudarshi D, Srikrishnan AK, Celentano DD, Vasudevan CK, Anand S, et al. Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India. Addiction. 2012;107(2):349\u201358 Epub 2011\/08\/06.","journal-title":"Addiction."},{"issue":"Suppl 2","key":"312_CR15","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/01.aids.0000327439.20914.33","volume":"22","author":"A Wodak","year":"2008","unstructured":"Wodak A, McLeod L. The role of harm reduction in controlling HIV among injecting drug users. AIDS. 2008;22(Suppl 2):S81\u201392 Epub 2008\/07\/25.","journal-title":"AIDS."},{"key":"312_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550 Epub 2017\/04\/28.","journal-title":"BMJ."},{"issue":"1","key":"312_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jocd.12675","volume":"18","author":"M Noroozi","year":"2019","unstructured":"Noroozi M, Armoon B, Ghisvand H, Noroozi A, Karimy M, Bazrafshan MR, et al. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran. J Cosmet Dermatol. 2019;18(1):258\u201362 Epub 2018\/05\/22.","journal-title":"J Cosmet Dermatol"},{"key":"312_CR18","volume":"9","author":"L Platt","year":"2017","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:CD012021. Epub 2017\/09\/19.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"312_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarcao J, Torre C, et al. Effectiveness of needle and syringe programmes in people who inject drugs - an overview of systematic reviews. BMC Public Health. 2017;17(1):309 Epub 2017\/04\/13.","journal-title":"BMC Public Health"},{"key":"312_CR20","first-page":"75","volume":"109","author":"D Vlahov","year":"1991","unstructured":"Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75\u2013100. Epub 1991\/01\/01.","journal-title":"NIDA Res Monogr"},{"issue":"5","key":"312_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/QAI.0b013e3182a7ee2e","volume":"64","author":"ML Salter","year":"2013","unstructured":"Salter ML, Lau B, Mehta SH, Go VF, Leng S, Kirk GD. Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquired Immune Defic Syndr. 2013;64(5):488\u201395. Epub 2013\/08\/28.","journal-title":"J Acquired Immune Defic Syndr"},{"issue":"4","key":"312_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1037\/1064-1297.8.4.483","volume":"8","author":"EM Kouri","year":"2000","unstructured":"Kouri EM, Pope HG Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000;8(4):483\u201392. Epub 2000\/12\/29.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"7","key":"312_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/aje\/kwg209","volume":"158","author":"N Galai","year":"2003","unstructured":"Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol. 2003;158(7):695\u2013704. Epub 2003\/09\/26.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"312_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00126334-200008150-00014","volume":"24","author":"M Safaeian","year":"2000","unstructured":"Safaeian M, Wilson LE, Taylor E, Thomas DL, Vlahov D. HTLV-II and bacterial infections among injection drug users. J Acquir Immune Defic Syndr. 2000;24(5):483\u20137 Epub 2000\/10\/18.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"312_CR25","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1086\/340827","volume":"185","author":"LE Wilson","year":"2002","unstructured":"Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. Prospective study of infective endocarditis among injection drug users. J Infect Dis. 2002;185(12):1761\u20136 Epub 2002\/06\/27.","journal-title":"J Infect Dis"},{"issue":"5","key":"312_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jinf.2012.12.012","volume":"66","author":"OS Sogaard","year":"2013","unstructured":"Sogaard OS, Reekie J, Ristola M, Jevtovic D, Karpov I, Beniowski M, et al. Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors. J Infect. 2013;66(5):439\u201346 Epub 2013\/01\/29.","journal-title":"J Infect"},{"issue":"12","key":"312_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri3547","volume":"13","author":"AC Shaw","year":"2013","unstructured":"Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013;13(12):875\u201387 Epub 2013\/10\/26.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"312_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cid\/cit596","volume":"58","author":"MA Huson","year":"2014","unstructured":"Huson MA, Stolp SM, van der Poll T, Grobusch MP. Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review. Clin Infect Dis. 2014;58(1):79\u201392 Epub 2013\/09\/21.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"312_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2648.2001.01672.x","volume":"33","author":"BA Hilton","year":"2001","unstructured":"Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature. J Adv Nurs. 2001;33(3):357\u201370. Epub 2001\/03\/17.","journal-title":"J Adv Nurs"},{"issue":"12","key":"312_CR30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/2047-783X-15-12-544","volume":"15","author":"P Kujath","year":"2010","unstructured":"Kujath P, Kujath C. Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens? Eur J Med Res. 2010;15(12):544\u201353 Epub 2010\/12\/18.","journal-title":"Eur J Med Res"},{"issue":"2","key":"312_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00284-016-1165-y","volume":"74","author":"D Dahlman","year":"2017","unstructured":"Dahlman D, Jalalvand F, Blome MA, Hakansson A, Janson H, Quick S, et al. High perineal and overall frequency of Staphylococcus aureus in people who inject drugs, compared to non-injectors. Curr Microbiol. 2017;74(2):159\u201367. Epub 2016\/11\/30.","journal-title":"Curr Microbiol"},{"issue":"5","key":"312_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/infdis\/jiq112","volume":"203","author":"SH Mehta","year":"2011","unstructured":"Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, et al. Changes in blood-borne infection risk among injection drug users. J Infect Dis. 2011;203(5):587\u201394 Epub 2011\/02\/02.","journal-title":"J Infect Dis"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0312-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:23:26Z","timestamp":1592263406000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0312-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0312-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical issues of the ALIVE study have been continually approved by the Johns Hopkins Institutional Review Board. All participants in this study had provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and have consented this submission for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}